DHR
Danaher Corporation Common Stock
- 看涨
- 0
- 看跌
- 0
- 观望
- 1
观望观点
- UNRIVALED INVESTING阅读完整报告
Danaher's highly recurring life-sciences franchise is durable, but current 2-3% core growth and a merely fair valuation fall short of an aggressive entry.
正在读取 ticker 详情…
正在加载创作者观点，请稍候。